These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2746842)

  • 1. [Determination of particulate matter in small volume antibiotic injections].
    Niizeki M; Tanno K
    Jpn J Antibiot; 1989 Mar; 42(3):567-72. PubMed ID: 2746842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particulate-matter content of 11 cephalosporin injections: conformance with USP limits.
    Parkins DA; Taylor AJ
    Am J Hosp Pharm; 1987 May; 44(5):1111-8. PubMed ID: 3605122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Particulate matter in four reconstituted cephalosporin injections.
    Kilarski DJ; Visconti JA; Frank SG
    Am J Hosp Pharm; 1983 Apr; 40(4):619-23. PubMed ID: 6846372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of acceptance criteria for particulate limits for small-volume parenteral products.
    Tsuji K; Lewis AR
    J Pharm Sci; 1978 Jan; 67(1):50-5. PubMed ID: 619115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particulate matter test in small volume parenterals: critical aspects in sampling methodology.
    Pavanetto F; Conti B; Genta I; Ponci R; Montanari L; Grassi M
    Farmaco; 1989 Jun; 44(6):633-43. PubMed ID: 2803449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical feasibility of sub-visible particle analysis in parenterals with reduced volume light obscuration methods.
    Hawe A; Schaubhut F; Geidobler R; Wiggenhorn M; Friess W; Rast M; de Muynck C; Winter G
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1084-7. PubMed ID: 23454051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Evaluation of Insoluble Particulate Matters in Therapeutic Protein Injections Using Light Obscuration and Flow Imaging Methods.
    Shibata H; Harazono A; Kiyoshi M; Ishii-Watabe A
    J Pharm Sci; 2022 Mar; 111(3):648-654. PubMed ID: 34619153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP perspectives on particle contamination of injectable products.
    Gallelli JF; Groves MJ
    J Parenter Sci Technol; 1993; 47(6):289-92. PubMed ID: 8120733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Particles in small volume injections.
    Taylor SA; Spence J
    J Pharm Pharmacol; 1983 Dec; 35(12):769-73. PubMed ID: 6141237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particulate matter determination in LVPs produced in Dutch hospital pharmacies. Part 2: Overview of the results.
    Boom FA; Van der Veen J; Verbrugge P; Van de Vaart FJ; Paalman AC; Vos T
    PDA J Pharm Sci Technol; 2000; 54(4):343-58. PubMed ID: 10969531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of sizing accuracy of particle counters for parenteral drugs.
    Fujishita O; Sendo T; Hisazumi A; Otsubo K; Aoyama T; Oishi R
    PDA J Pharm Sci Technol; 1995; 49(6):267-71. PubMed ID: 8581457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particulate contamination in solutions of antibiotics packed as dry powders in vials.
    Alexander DM; Veltman AM
    J Pharm Pharmacol; 1988 May; 40(5):358-9. PubMed ID: 2899632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interlaboratory comparison about feasibility of insoluble particulate matter test for injections with reduced test volume in light obscuration method.
    Harazono A; Shibata H; Kiyoshi M; Muto T; Fukuda J; Torisu T; Saitoh S; Nishimura H; Uchiyama S; Ishii-Watabe A
    Biologicals; 2019 Jan; 57():46-49. PubMed ID: 30553568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Particulate contamination in parenterals: current issues.
    Groves MJ
    Boll Chim Farm; 1991 Oct; 130(9):347-54. PubMed ID: 1799429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleanliness assessment of supplier-cleaned stoppers.
    Townsend MW; Conti B; Hazrati A; DeLuca PP
    J Parenter Sci Technol; 1989; 43(2):98-102. PubMed ID: 2709242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative estimation of particulate matter in pharmaceutical preparations intended for intravenous administration.
    Bikhazi AB; Shiatis JA; Haddad AF
    J Pharm Sci; 1977 Feb; 66(2):181-6. PubMed ID: 839413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Particulate Generation Mechanisms during Bulk Filling and Mitigation via New Glass Vial.
    Timmons CL; Liu CY; Merkle S
    PDA J Pharm Sci Technol; 2017; 71(5):379-392. PubMed ID: 28512178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of improved standardization methods and instrumentation in the USP particulate test for SVI.
    Barber TA; Lannis MD; Williams JG; Ryan JF
    J Parenter Sci Technol; 1990; 44(4):185-203. PubMed ID: 2213427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of protein particles in parenteral solutions using micro-flow imaging.
    Huang CT; Sharma D; Oma P; Krishnamurthy R
    J Pharm Sci; 2009 Sep; 98(9):3058-71. PubMed ID: 18937372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Particulate evaluation of parenteral nutrition solutions by electronic particle counting and scanning electron microscopy.
    Akers MJ; Schrank GD; Russell S
    Am J Hosp Pharm; 1981 Sep; 38(9):1304-7. PubMed ID: 6792911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.